Concord Wealth Partners’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-19
| Closed | -$121 | – | 1116 |
|
|
2022
Q4 | $121 | Buy |
+19
| New | +$121 | ﹤0.01% | 1220 |
|
|
2022
Q3 | – | Sell |
-90
| Closed | -$1K | – | 627 |
|
|
2022
Q2 | $1K | Sell |
90
-514
| -85% | -$5.71K | ﹤0.01% | 1145 |
|
|
2022
Q1 | $10K | Sell |
604
-413
| -41% | -$6.84K | ﹤0.01% | 780 |
|
|
2021
Q4 | $19K | Buy |
1,017
+447
| +78% | +$8.35K | ﹤0.01% | 657 |
|
|
2021
Q3 | $14K | Buy |
570
+312
| +121% | +$7.66K | 0.01% | 425 |
|
|
2021
Q2 | $7K | Sell |
258
-150
| -37% | -$4.07K | ﹤0.01% | 685 |
|
|
2021
Q1 | $13K | Buy |
408
+369
| +946% | +$11.8K | ﹤0.01% | 540 |
|
|
2020
Q4 | $2K | Buy |
+39
| New | +$2K | ﹤0.01% | 536 |
|